{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:54:37Z","timestamp":1780545277197,"version":"3.54.1"},"reference-count":27,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,12]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>M2BPGi is increased in patients with liver graft-versus-host disease, especially in those at high risk for late NRM after allogeneic HSCT. WFA+-M2BP\u2013positive macrophages are found in liver graft-versus-host disease, supporting these cells as a responder of this glycoprotein.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000629","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T11:42:18Z","timestamp":1572608538000},"page":"3287-3296","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT"],"prefix":"10.1182","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-9340","authenticated-orcid":false,"given":"Yu","family":"Akahoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9315","authenticated-orcid":false,"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machiko","family":"Kusuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-9233","authenticated-orcid":false,"given":"Shunto","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Misaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Gomyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Tanihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"issue":"2","key":"2019111521182792800_B1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","article-title":"Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood"},{"issue":"16","key":"2019111521182792800_B2","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111521182792800_B3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation","volume":"341","author":"Soci\u00e9","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111521182792800_B4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bmt.1705434","article-title":"Quality of life associated with acute and chronic graft-versus-host disease","volume":"38","author":"Lee","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2019111521182792800_B5","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bbmt.2017.06.011","article-title":"Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease","volume":"23","author":"Kurosawa","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"2019111521182792800_B6","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2018-02-791509","article-title":"Biomarkers for posttransplantation outcomes","volume":"131","author":"Paczesny","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2019111521182792800_B7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report","volume":"21","author":"Paczesny","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2019111521182792800_B8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41409-018-0092-x","article-title":"Biomarkers in chronic graft-versus-host disease: quo vadis?","volume":"53","author":"Wolff","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111521182792800_B9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111521182792800_B10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","article-title":"Chronic graft-versus-host disease: biological insights from preclinical and clinical studies","volume":"129","author":"MacDonald","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2019111521182792800_B11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"2019111521182792800_B12","doi-asserted-by":"crossref","first-page":"15690","DOI":"10.1074\/jbc.M200386200","article-title":"Functional studies on recombinant domains of Mac-2-binding protein","volume":"277","author":"Hellstern","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"2019111521182792800_B13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","article-title":"A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis","volume":"3","author":"Kuno","year":"2013","journal-title":"Sci Rep"},{"issue":"6","key":"2019111521182792800_B14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/14789450.2015.1084874","article-title":"Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis\/cirrhosis diagnostics","volume":"12","author":"Narimatsu","year":"2015","journal-title":"Expert Rev Proteomics"},{"issue":"3","key":"2019111521182792800_B15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2019111521182792800_B16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2019111521182792800_B17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/jgh.13708","article-title":"Hepatic stellate cells secreting WFA+ -M2BP: its role in biological interactions with Kupffer cells","volume":"32","author":"Bekki","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"2019111521182792800_B18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2019111521182792800_B19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/leu.2011.257","article-title":"Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study","volume":"26","author":"Kuzmina","year":"2012","journal-title":"Leukemia"},{"issue":"9","key":"2019111521182792800_B20","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.bbmt.2016.06.003","article-title":"Risk factors and impact of secondary failure of platelet recovery after allogeneic stem cell transplantation","volume":"22","author":"Akahoshi","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2019111521182792800_B21","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1039\/c3cs35419a","article-title":"Lectin microarrays: concept, principle and applications","volume":"42","author":"Hirabayashi","year":"2013","journal-title":"Chem Soc Rev"},{"issue":"18","key":"2019111521182792800_B22","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2017-01-758854","article-title":"Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-\u03b2 production","volume":"129","author":"Du","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2019111521182792800_B23","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3324\/haematol.2014.109611","article-title":"Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease","volume":"99","author":"Inamoto","year":"2014","journal-title":"Haematologica"},{"issue":"12","key":"2019111521182792800_B24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s00535-017-1345-y","article-title":"Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury","volume":"52","author":"Morio","year":"2017","journal-title":"J Gastroenterol"},{"issue":"2","key":"2019111521182792800_B25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jgh.14438","article-title":"Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation","volume":"34","author":"Yamada","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"14","key":"2019111521182792800_B26","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.3748\/wjg.v21.i14.4284","article-title":"Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients","volume":"21","author":"Liao","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2019111521182792800_B27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/bmt.2015.205","article-title":"Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation","volume":"51","author":"Arai","year":"2016","journal-title":"Bone Marrow Transplant"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/21\/3287\/1505921\/advancesadv2019000629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/21\/3287\/1505921\/advancesadv2019000629.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T23:47:44Z","timestamp":1573861664000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/21\/3287\/422672\/Increased-Mac2-binding-protein-glycan-isomer-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":27,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2019,11,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000629","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}